Fondazione Policlinico Universitario Agostino Gemelli IRCCS

• Artificial Intelligence Software (Prostate Intelligence) for Detecting Clinically Significant Prostate Cancer on MRI

  Not yet recruiting, 226 people

• NCT06959979

  Early phase 1, Recruiting, 60 people, 7 May 2025

• NCT06946420

  Phase 3, Active, not recruiting, 108 people, 27 Apr 2025

• NCT06884683

  Phase 2, Terminated, 12 people, 19 Mar 2025

• NCT06283381

  Phase 4, Status unknown, 40 people, 28 Feb 2024

• NCT05970770

  Phase 4, Status unknown, 150 people, 1 Aug 2023

• NCT05736887

  Phase 2, Status unknown, 80 people, 21 Feb 2023

• Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

  Collaborator, Phase 3, Recruiting, 316 people, 24 Feb 2022

• NCT05203913

  Phase 2, Status unknown, 32 people, 24 Jan 2022

• NCT04679064

  Phase 3, Status unknown, 427 people, 22 Dec 2020

• NCT04421547

  Phase 3, Terminated, 86 people, 9 Jun 2020

• NCT04261465

  Phase 2, Status unknown, 35 people, 7 Feb 2020

• NCT04238988

  Phase 2, Status unknown, 45 people, 23 Jan 2020

• NCT03645603

  Collaborator, Phase 2, Terminated, 45 people, 24 Aug 2018

• NCT03462212

  Phase 1/2, Status unknown, 290 people, 12 Mar 2018

• NCT02903004

  Phase 3, Completed, 242 people, 16 Sept 2016

• NCT02020694

  Phase 4, Completed, 60 people, 25 Dec 2013

Sources: clinicaltrials.gov

• European Commission

  HORIZON-JU-RIA, Unleashing a CoMprehensive, Holistic and Patient Centric Stroke Management for a Better, Rapid, AdvancEd and PersonaLised Stroke Diagnosis, TreAtment and Outcome Prediction, 101172825, €647.3k, 2024–2029, 31 Jul 2024

• European Commission

  HORIZON-RIA, Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty, 101137301, €947.5k, 2024–2027, 7 Dec 2023

Sources: cordis.europa.eu